SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CLZR:a potential 10 bagger?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bob Davis who wrote (79)10/19/1998 1:35:00 PM
From: Bob Davis  Read Replies (1) of 315
 
CLZR has just released its financial results for its first quarter of
fiscal 1999, reporting record revenues and EPS of $0.16 per share, versus a loss in the prior year's quarter. This is further proof that the CLZR turnaround is taking place.

Last thursday CLZR announced completion of a new debt financing package. "This capital infusion adds significantly to our financial strength, so that we can capitalize more rapidly on the growing market opportunities we are seeing in our laser device business."

CLZR is followed by The Napeague Letter, which can be found at napeague.com

Bob Davis
The Napeague Letter
napeague.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext